Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area Sort ascending
Country
Application Due Date
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines Italy
Gene and Gene-modified Cell Therapies Medical Education
Release Date:
Partner: American Society of Gene + Cell Therapy
Review Process: Expert Review Panel
Education Rare Disease All
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Rare Disease Canada
Sickle Cell Disease (SCD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Pathological diagnosis and Immunohistochemistry biomarker assessments of Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Ghana
Title
Grant Type
Focus Area Sort ascending
Country
Application Due Date
Improving ATTR Amyloidosis Management in Spain
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Spain
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Quality Improvement Grants to Support the Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Canada
Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Mayo Clinic
Review Process: Expert Review Panel
Translation: French (link)
Translation: Spanish (link)
Translation: Mandarin (link)
Translation: Arabic (link)
Quality Improvement Rare Disease All
Hemophilia Research in Africa-Middle East, Asia Pacific, China and Latin America
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Hemophilia: Improve Knowledge Level of Gene Therapy
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR-CM in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Rare Disease Canada
2022 Hemophilia ASPIRE-Africa Middle East, Asia-Pacific, & Latin America
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
2021 Global Hemophilia ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Increase HCP knowledge of Gene Therapy management
Release Date:
Review Process: Pfizer Internal
Education Rare Disease China
Cardiac Amyloidosis Mentor mATTch pRogram
Release Date:
Partner: Amyloidosis Foundation
Review Process: Pfizer Internal
Education Rare Disease USA